Lynette Herscha

Lynette Herscha has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Solid Biosciences Inc. and Concert Pharmaceuticals, Inc. In total, 7 filings cover trades dated from 6 July 2017 to 28 July 2020.

The open-market record consists of 1 sale worth €11k, with no purchase. Outside the open market, there are 5 share grants and 1 option exercise. 2020 to date brings no purchases and 1 sale.

The latest filing, published on 29 July 2020, reports an option exercise in Solid Biosciences Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.